Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Political Uncertainty Weighs on Markets as Trump Approval Rating Drops to 35 Wall Street Grows More Cautious on LongTerm Inflation Outlook Dow Slides Home Depot Weighs on RetailFocused Week Nasdaq Extends Losses Reid Hoffman Raises 246 Million for AIPowered Cancer Research Startup Manas AI EuroZone Business Activity Contracts at Sharpest Pace Since 2023 Raising Economic Concerns CBSE Board Exam Portal Vulnerability Raises Data Security Concerns NRx Pharmaceuticals NRXP Gains Attention as Wall Street AnalystRated Penny Stock BristolMyers Squibb BMY A Dividend Stock Gaining Hedge Fund Attention Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project SpaceXs Starship Launch Amid Fuel Crisis Climate Questions Loom PagSeguro Digital Ltd PAGS Q1 2026 Earnings Narrow EPS Miss as Costs Offset Revenue Growth FROG Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction eGain Q1 2026 Earnings EPS Beats Estimates by Over 54 LYEL Q1 2026 Earnings EPS Surpasses Estimates Despite Continued Revenue Absence JANX Q1 2026 Earnings NarrowerthanExpected Loss Buoys Biotech Sentiment ALNT Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Gain Eupraxia Pharmaceuticals EPRX Gains 279 as Stock Tests Resistance Near 775 eToro Group ETOR Gains Ground Testing Resistance After 313 Rally Southside Bancshares SBSI Shows Modest Gains as Stock Hovers Near Key Support Levels Selective Insurance Group SIGI Holds Steady Near 89 as Consolidation Continues Myers Industries MYE Surges 386 Approaching Resistance Amid Renewed Buying Interest Quad Graphics QUAD Holds Near Support as Modest Gains Persist Ernexa Therapeutics Warrants ERNAW Surge 14 as Price Tests Key Resistance Level Nuveen Pennsylvania Quality Municipal Income Fund NQP Holds Steady Amid Municipal Bond Market Calm Legacy Education LGCY Slips 17 as Stock Tests Key Support Zone Atara Biotherapeutics ATRA Faces Selling Pressure Near Key Resistance Zone RGCO Slips 095 as Shares Trade Near Midrange Support